Relative Bioavailability of Three Newly Developed Albendazole Formulations: a Randomized Crossover Study with Healthy Volunteers

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 48; no. 3; pp. 1051 - 1054
Main Authors Rigter, I. M., Schipper, H. G., Koopmans, R. P., van Kan, H. J. M., Frijlink, H. W., Kager, P. A., Guchelaar, H.-J.
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.03.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Undefined-3
Corresponding author. Present address: Leiden University Medical Center, Clinical Pharmacy & Toxicology, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Phone: 31 70 526 2790. Fax: 011 31 71 524 8101. E-mail: h.j.guchelaar@lumc.nl.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.48.3.1051-1054.2004